Market closed
ICON plc/$ICLR
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.
Ticker
$ICLR
Sector
Trading on
Industry
Life Sciences Tools & Services
Headquarters
Dublin, Ireland
Employees
42,250
Website
ICON plc Metrics
BasicAdvanced
$17B
Market cap
23.16
P/E ratio
$8.99
EPS
1.25
Beta
-
Dividend rate
Price and volume
Market cap
$17B
Beta
1.25
52-week high
$347.72
52-week low
$183.38
Average daily volume
1.5M
Financial strength
Current ratio
1.341
Quick ratio
1.291
Long term debt to equity
36.299
Total debt to equity
36.604
Interest coverage (TTM)
4.29%
Management effectiveness
Return on assets (TTM)
4.17%
Return on equity (TTM)
7.98%
Valuation
Price to earnings (TTM)
23.159
Price to revenue (TTM)
2.071
Price to book
1.76
Price to tangible book (TTM)
-5.89
Price to free cash flow (TTM)
13.996
Growth
Revenue change (TTM)
3.63%
Earnings per share change (TTM)
44.69%
3-year revenue growth (CAGR)
24.01%
3-year earnings per share growth (CAGR)
45.15%
What the Analysts think about ICON plc
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for ICON plc stock.
ICON plc Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
ICON plc Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
ICON plc News
AllArticlesVideos
ICON: A High Probability Of Success In The Uncertain R&D Process
Seeking Alpha·2 days ago
Bronstein, Gewirtz & Grossman, LLC Is Investigating ICON Public Limited Company (ICLR) And Encourages Investors to Connect
Accesswire·2 days ago
Bronstein, Gewirtz & Grossman, LLC Encourages ICON Public Limited Company (ICLR) Stockholders to Inquire about Securities Investigation
Accesswire·3 days ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for ICON plc stock?
ICON plc (ICLR) has a market cap of $17B as of December 15, 2024.
What is the P/E ratio for ICON plc stock?
The price to earnings (P/E) ratio for ICON plc (ICLR) stock is 23.16 as of December 15, 2024.
Does ICON plc stock pay dividends?
No, ICON plc (ICLR) stock does not pay dividends to its shareholders as of December 15, 2024.
When is the next ICON plc dividend payment date?
ICON plc (ICLR) stock does not pay dividends to its shareholders.
What is the beta indicator for ICON plc?
ICON plc (ICLR) has a beta rating of 1.25. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.